Ghrelin and depressive symptoms in patients with first-episode drug-naïve major depressive disorder: The mediating role of hypothalamic-pituitary-adrenal axis

被引:0
|
作者
Zhang, Chuhao [1 ]
Dong, Yeqing [1 ]
Li, Shuhua [1 ,2 ]
Li, Meijuan [1 ]
Gao, Ying [1 ]
Liu, Yuan [1 ]
Liu, Xueying [1 ]
Zhou, Chi [1 ]
Li, Jie [1 ,3 ]
机构
[1] Tianjin Med Univ, Tianjin Anding Hosp, Inst Mental Hlth, Mental Hlth Ctr, Tianjin, Peoples R China
[2] Tianjin TEDA Hosp, Dept Clin Psychol, Tianjin, Peoples R China
[3] Tianjin Med Univ, Tianjin Anding Hosp, Inst Mental Hlth, Mental Hlth Ctr, 13 Liulin Rd, Tianjin 300222, Peoples R China
关键词
depressive symptoms; ghrelin; hypothalamic-pituitary-adrenal axis; major depressive disorder; SERUM GHRELIN; LEPTIN LEVELS; STRESS; ANXIETY; BEHAVIOR; MEMORY; FOOD; RESILIENCE; MECHANISMS; APPETITE;
D O I
10.1111/appy.12552
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Major depressive disorder (MDD) is one of the global burdens of disease, and its pathogenesis remains unclear. An increasing amount of research indicates that ghrelin regulates mood in patients with MDD. Still, current results are inconsistent, and the mechanisms underlying how ghrelin modulates depressive symptoms are inconclusive, especially in first-episode drug-na & iuml;ve MDD patients. Therefore, this study aims to investigate the relationship and potential mechanism between ghrelin and first-episode drug-na & iuml;ve MDD. Methods: Ninety first-episode drug-na & iuml;ve MDD patients and 65 healthy controls (HCs) were included. Hamilton Depression Scale (HAMD-17) as a measure of depressive symptoms. Plasma levels of ghrelin and hypothalamic-pituitary-adrenal axis (HPA-axis) hormones were measured in all participants. Results: Compared to HCs, the ghrelin levels were higher in the MDD (p < .001) and still showed significance after covarying for sex, age, and Body Mass Index (BMI). Ghrelin was positively related to corticotropin-releasing-hormone (CRH) levels (r = .867, p < .001), adrenocorticotropic hormone (ACTH) levels (r = .830, p < .001), and cortisol levels (r = .902, p < .001) in partial correlation analysis. In addition, there was a positive correlation between HAMD total score and ghrelin levels (r = .240, p = .026). Other than that, the HAMD total score also had a positive correlation with the CRH (r = .333, p = .002) and cortisol (r = .307, p = .004) levels. Further mediation analysis demonstrated that the relationship between ghrelin and HAMD total score was mediated by CRH (ab-path; beta = .4457, 95% CI = 0.0780-1.0253, c-path; beta = .2447, p = .0260, c '-path; beta = -.2009, p = .3427). Conclusions: These findings revealed that plasma ghrelin provides a pivotal link to depressive symptoms in first-episode drug-naive MDD patients. CRH mediated the relationship between ghrelin and HAMD total score. It might provide new insights into understanding the pathogenesis of MDD, contributing to intervention and treatment from this approach.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Prevalence and risk factors for psychotic symptoms in young, first-episode and drug-naïve patients with major depressive disorder
    Yuxuan Wu
    Xueli Zhao
    Zhe Li
    Ruchang Yang
    Ruijie Peng
    Yue Zhou
    Xingzhi Xia
    Hanxu Deng
    Xiaobin Zhang
    Xiangdong Du
    Xiangyang Zhang
    [J]. BMC Psychiatry, 24
  • [2] Prevalence and risk factors for psychotic symptoms in young, first-episode and drug-naïve patients with major depressive disorder
    Wu, Yuxuan
    Zhao, Xueli
    Li, Zhe
    Yang, Ruchang
    Peng, Ruijie
    Zhou, Yue
    Xia, Xingzhi
    Deng, Hanxu
    Zhang, Xiaobin
    Du, Xiangdong
    Zhang, Xiangyang
    [J]. BMC PSYCHIATRY, 2024, 24 (01)
  • [3] Cytokine profile in first-episode drug-naïve major depressive disorder patients with or without anxiety
    Jun Liang
    Yayun Xu
    Wenfan Gao
    Yanhong Sun
    Yuanyuan Zhang
    Feng Shan
    Qingrong Xia
    [J]. BMC Psychiatry, 24
  • [4] Memory and processing speed impairments in first-episode drug-na?ve patients with major depressive disorder
    Hu, Yongbo
    Li, Jin
    Zhao, Youjin
    Dong, Zaiquan
    Qiu, Peiyuan
    Yang, Shujuan
    Xu, Haizhen
    Kuang, Weihong
    Gong, Qiyong
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2023, 322 : 99 - 107
  • [5] Aberrant interhemispheric functional connectivity in first-episode, drug-naïve major depressive disorder
    Hong Yang
    Chengwei Wang
    Gongjun Ji
    Zhan Feng
    Jingfeng Duan
    Feng Chen
    Xiaohong Joe Zhou
    Yushu Shi
    Haiyan Xie
    [J]. Brain Imaging and Behavior, 2019, 13 : 1302 - 1310
  • [6] Prevalence and risk factors of anxiety symptoms in first-episode and drug-naïve major depressive disorder patients with metabolic syndrome
    Liu, Jizhou
    Yang, Yonglan
    Zhang, Yanjiang
    Wang, Haifeng
    Wei, Wenjian
    Lang, Xiaoe
    Zhang, Xiangyang
    [J]. EUROPEAN JOURNAL OF PSYCHIATRY, 2023, 37 (04):
  • [7] Duration of untreated illness and clinical correlates in first-episode and drug-na?ve patients with major depressive disorder
    Luo, Guoshuai
    Li, Yaxi
    Yao, Cong
    Li, Meijuan
    Li, Jie
    Zhang, Xiangyang
    [J]. PSYCHIATRY RESEARCH, 2023, 320
  • [8] Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
    Reiji Yoshimura
    Taro Kishi
    Hikaru Hori
    Kiyokazu Atake
    Asuka Katsuki
    Wakako Nakano-Umene
    Atsuko Ikenouchi-Sugita
    Nakao Iwata
    Jun Nakamura
    [J]. Annals of General Psychiatry, 13
  • [9] Development and validation of a nomogram for suicide attempts in patients with first-episode drug-naïve major depressive disorder
    Liu, Junjun
    Tong, Ruixiang
    Lu, Zhaomin
    Wang, Zhiye
    Wang, Yangchun
    Liu, Yang
    Yuan, Hsinsung
    Jia, Fengnan
    Zhang, Xiaobin
    Li, Zhe
    Du, Xiangdong
    Zhang, Xiangyang
    [J]. FRONTIERS IN PSYCHIATRY, 2024, 15
  • [10] Functional connectivity of the default mode network in first-episode drug-naïve patients with major depressive disorder
    Qiu, Hui
    Zhang, Lianqing
    Gao, Yingxue
    Zhou, Zilin
    Li, Hailong
    Cao, Lingxiao
    Wang, Yingying
    Hu, Xinyue
    Liang, Kaili
    Tang, Mengyue
    Kuang, Weihong
    Huang, Xiaoqi
    Gong, Qiyong
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2024, 361 : 489 - 496